Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 20, 2023, titled “Glenmark Pharmaceuticals receives ANDA approval for Prochlorperazine MaleateTablets USP, 5 mg and 10 mg”…….
| Subscribe To Our Free Newsletter |
